Androgenetic Alopecia
Industrial Farmaceutica Cantabria S.A. supports clinical research in androgenetic alopecia, with a focus on treatments aimed at improving scalp hair density and slowing progressive hair loss. The sponsored studies address both efficacy and safety in this dermatologic condition.
- Hair regrowth
- Scalp hair density
- Topical and oral treatment options
The research activity includes evaluation of minoxidil-based approaches in women affected by hormone-related alopecia.
Female Pattern Hair Loss
The sponsor is also active in female androgenetic alopecia, a therapeutic area centered on chronic thinning of the scalp hair in women. Its trials reflect interest in clinical outcomes relevant to women with hormone-imbalanced hair loss.
- Women’s dermatology
- Hormone-related alopecia
- Non-vellus hair count
This area of research supports assessment of visible hair restoration and tolerability in a female population.
Minoxidil Formulations
Clinical interest extends to oral minoxidil and topical minoxidil, with attention to how different formulations are used in hair restoration research. The sponsor’s portfolio includes comparisons involving placebo and topical vehicle controls.
- Oral minoxidil
- Topical minoxidil
- Vehicle-controlled treatment
These studies align with therapeutic development in dermatology, particularly for patients seeking non-surgical options for scalp alopecia.
Dermatology and Hair Disorders
The sponsor’s clinical research landscape is concentrated in dermatology, especially disorders affecting the hair follicle and scalp. Its funded trials are directed toward measurable changes in hair growth and treatment response.
- Hair follicle disorders
- Scalp conditions
- Clinical evaluation of hair growth
Research activity in this field supports therapeutic interest in chronic, non-scarring forms of alopecia.
